Staar Surgical Announces $50M Share Buyback, Driving Stock Up Over 7%
On Friday, Staar Surgical (NASDAQ: STAA) announced a new share buyback program authorizing up to $50 million in repurchases of its common stock. The move led investors to push the company's shares more than 7% higher for the day. CEO Warren Foust stated that the initiative reflects confidence in the business, strong balance sheet, and ample free cash flow, as well as a belief that Staar is currently undervalued. The buyback program has no fixed end date but is expected to last approximately one year. The company will repurchase shares through open-market transactions or structured agreements with third parties at its discretion. In the second quarter of 2026, Staar more than doubled its net sales and reported a headline net profit while holding nearly $149 million in cash. Analysts suggest that for niche businesses like Staar Surgical, share repurchases can help attract investor interest and support stock prices. The market's positive reaction to the news is seen as justified given the company’s strong financial position.
Tickers: $STAA
Topics: buyback share repurchase Staar Surgical